Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3H3RX | — |
Engerix-B, it was expired back in July 2024; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 29-year-old female patient who received HBV (Engerix B) (batch number 3H3RX, expiry date 12-JUL-2024) for prophylaxis. On 31-MAR-2025, the patient received Engerix B. On 31-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Engerix-B, it was expired back in July 2024). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-MAR-2025 On 31-Mar-2025 a Registered pharmacist called and reported that a patient of mine received a vaccine Engerix-B, it was expired back in July 2024, which led to expired vaccine used. Reporter was wondering if had information on extended expiration on that, or what the revaccination guidelines were for this particular accident. The Vaccine Administration Facility is the same as Primary Reporter. The patient received the vaccine on the day of reporting, 31-Mar-2025.